A c-Met Inhibitor Suppresses Osteosarcoma Progression via the ERK1/2 Pathway in Human Osteosarcoma Cells

A c-Met Inhibitor Suppresses Osteosarcoma Progression via the ERK1/2 Pathway in Human Osteosarcoma Cells

Weijie Chen,1– 3,* Su Wu,4,* Yang Huang,3,* Tingting Zhang,5 Hao Dong,6 Xing Zheng,3 Tao Chen,3 Xiaokang Gong,3 Gang Liu,1,2 Xing Zhao1 1Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, HangZhou, People’s Republic of China;...

Full description

Bibliographic Details
Main Authors: Chen W, Wu S, Huang Y, Zhang T, Dong H, Zheng X, Chen T, Gong X, Liu G, Zhao X
Format: Article
Language:English
Published: Dove Medical Press 2021-09-01
Series:OncoTargets and Therapy
Subjects:
osteosarcoma
met
pha-665752
erk signaling
ly3214996
Online Access:https://www.dovepress.com/a-c-met-inhibitor-suppresses-osteosarcoma-progression-via-the-erk12-pa-peer-reviewed-fulltext-article-OTT

Internet

https://www.dovepress.com/a-c-met-inhibitor-suppresses-osteosarcoma-progression-via-the-erk12-pa-peer-reviewed-fulltext-article-OTT

Similar Items